Archives
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
IGU Prodrug Disrupts STAT1–C3–TNFα Crosstalk
2026-10-01
The reference study identifies TYK2 JH2-dependent control of STAT1 as a mechanism by which iguratimod suppresses rheumatoid arthritis fibroblast-like synoviocyte invasiveness. It further shows that an iguratimod prodrug, AD811, preserves activity in collagen-induced arthritis while interrupting a complement C3–TNFα feedback loop between synovial fibroblasts and macrophages.
-
Eldecalcitol and Endothelial Ferroptosis in T2DOP
2026-10-01
A 2025 study identifies endothelial ferroptosis as a mechanistic contributor to type 2 diabetic osteoporosis and connects the protective activity of eldecalcitol to the SOCE/O-GlcNAcylation axis. Its combined cell and mouse experiments link calcium signaling, lipid oxidation, angiogenesis, and osteogenesis, providing a framework for evaluating vascular mechanisms in diabetic bone disease.
-
Tiamulin (Thiamutilin) for PK/PD Research
2026-09-30
Tiamulin combines targeted pleuromutilin antibacterial activity with an emerging anti-inflammatory research profile, making it useful for both pathogen-focused and pathway-focused workflows. This guide translates chicken infection-model PK/PD findings into practical assay design, dosing interpretation, and troubleshooting steps.
-
Direct Mouse Genotyping Kit Plus for Disease Models
2026-09-30
The Direct Mouse Genotyping Kit Plus supports rapid, purification-free PCR workflows for complex mouse genotyping assays. This article connects genotype quality control with the EP4–CD36 atherosclerosis model, showing how assay design can strengthen mechanistic interpretation.
-
STMN2 Depletion, Translation Deficits, and Stress Granules
2026-09-29
The reference study shows that stress can deplete neuronal STMN2 through proteasomal degradation, phosphorylation, and stress-granule-associated translation repression, independently of TDP-43 splicing dysfunction. Its combination of neuronal models, single-molecule translation and RNA-localization analyses, pharmacological perturbations, and longitudinal survival measurements provides a broader framework for understanding STMN2 vulnerability in ALS.
-
Azilsartan as a Causal Probe of Glial RAS
2026-09-29
Azilsartan (TAK-536) offers translational researchers a selective way to test whether AT1 signaling connects microglia-derived inflammatory cues with reactive astrocyte phenotypes. This thought-leadership article interprets recent RAS–SIRT3 findings, proposes a disciplined assay framework, and defines what remains to be demonstrated beyond cell-based models.
-
Ruxolitinib Phosphate: JAK Signaling to Mitochondria
2026-09-28
A translational perspective on how Ruxolitinib phosphate and INCB018424 connect JAK1/2 inhibition with STAT3-dependent mitochondrial dynamics, apoptosis, and pyroptosis in anaplastic thyroid carcinoma research.
-
TTP–WTAP–m⁶A Signaling Limits Schistosomal Fibrosis
2026-09-28
A 2026 study identifies tristetraprolin (TTP) as a protective regulator of Schistosoma japonicum–induced liver fibrosis, linking TTP to WTAP transcription and m⁶A-dependent destabilization of TGF-β1 mRNA. The results extend TTP biology beyond its canonical role in mRNA decay and suggest a pathway for investigation, while leaving important questions about cell specificity and therapeutic translation.
-
3-Deazaadenosine for Methylation Pathway Research
2026-09-27
Use 3-Deazaadenosine as a broad pharmacological probe to test whether methylation capacity contributes to inflammatory or viral phenotypes—not as a selective METTL14 inhibitor. A staged dose-and-time workflow helps separate pathway effects from cytotoxicity and connects the ulcerative-colitis findings of Wu et al. to experimentally testable hypotheses.
-
Optimizing Functional Platelet Production from hiPSCs
2026-09-26
Yue and colleagues optimized an embryoid-body-based hiPSC differentiation workflow by adjusting cell input and culture conditions and incorporating small molecules at distinct stages. The reported protocol produced thrombin-responsive platelets in 19 days, with higher output and lower reported costs, while its results should not be attributed to SU6656, which was not part of the highlighted maturation combination.
-
Tiamulin (Thiamutilin): PK/PD Workflows
2026-09-25
Use Tiamulin to connect ribosomal target engagement with practical antibacterial and inflammation-assay questions. A chicken infection study shows why exposure relative to MIC—not dose alone—is the more informative guide for interpreting efficacy.
-
Amikacin Sulfate: Workflows for Infection Models
2026-09-25
Build practical Amikacin Sulfate workflows for bacterial susceptibility, CFU killing, and intracellular uptake studies. The guide pairs reported activity data with assay controls and troubleshooting, while flagging a MIC-unit discrepancy that should be resolved before experiments are interpreted.
-
Covalent HPV16 E6 Inhibition Restores p53
2026-09-24
The study reports covalent inhibitors that irreversibly inactivate HPV-16 E6, restore p53 signaling, and suppress growth of HPV-driven cervical and oropharyngeal tumors in mouse models. Genetic resistance controls support an on-target mechanism, while the reported senescence response may be studied as a complementary cellular phenotype—not as a substitute for measuring E6 inhibition or p53 restoration.
-
BMPSB4 Drives Autophagy in Corticotroph PitNETs
2026-09-24
A 2024 study reports that the BMP4-pathway agonist BMPSB4 activates SMAD1/5/9, induces autophagy, and suppresses corticotroph pituitary tumor cells. Cell and in vivo findings support further study of this pathway in Cushing’s disease, while leaving important questions about clinical translation and mechanism unresolved.
-
Norovirus Redirects NINJ1 for Selective NS1 Secretion
2026-09-23
Song and colleagues show that murine norovirus uses caspase-3 processing and the host membrane-rupture protein NINJ1 to release viral NS1, while NINJ1 also supports bulk release of cellular damage signals. The work identifies a selective unconventional secretion route with relevance to intestinal infection, while leaving open how cargo recognition and membrane rupture are coordinated.